Haematological trials

We can deliver early and late phase, commercial and non-commercial clinical trials that are high to moderate risk complex drugs trials including advanced therapies of medicinal products and BiTEs. Our globally recognised clinicians are responsible for trials that are driving cutting-edge novel treatments that advance cancer treatment and care.

Case study: MonumenTAL-6

A study comparing the effectiveness of the drugs Tal-pomalidomide (Tal-P) or Tal-Tec when taken in combination with others to treat blood cancer.